Pyrexia, commonly known as fever, is a prevalent clinical symptom indicating an underlying pathophysiological process. It is often a protective response to various stimuli, including infections, malignancies, or immune disorders. Understanding its mechanisms, diagnostic approaches, and management strategies is crucial for all healthcare professionals.
Pyrexia results from a complex interplay of cytokines, prostaglandins, and the hypothalamus. Pyrogens, substances that can induce fever, trigger the release of cytokines such as interleukin-1 and tumour necrosis factor. These cytokines stimulate the production of prostaglandin E2 (PGE2) in the hypothalamus, resetting the body's 'thermostat' to a higher level, leading to fever.
A comprehensive history and physical examination form the cornerstone of pyrexia diagnosis. It is essential to identify potential sources of infection, exposure history, travel history, and associated symptoms. Laboratory investigations, including complete blood count, blood cultures, and imaging studies, may be required depending on the clinical context.
Management of pyrexia involves treating the underlying cause and symptomatic relief. Antipyretics, such as paracetamol and non-steroidal anti-inflammatory drugs (NSAIDs), are commonly used for symptom control. However, the decision to treat fever should be individualized, considering the patient's comfort and the potential benefits of fever in fighting infections.
In cases where infection is the identified cause of fever, appropriate antimicrobial therapy is crucial. Empirical therapy should be initiated promptly in septic patients, followed by targeted therapy based on culture and sensitivity results.
Pyrexia is a complex clinical symptom with diverse etiologies. A systematic approach to diagnosis and management, understanding the role of fever in the host defense mechanism, and judicious use of antipyretics can optimize patient outcomes. Continuous research is required to further our understanding of pyrexia and improve its management.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation